Farmabarocco: Curcumin for metabolic syndrome
The metabolic syndrome refers to the co-occurrence of several known cardiovascular risk factors, including insulin resistance, obesity, atherogenic dyslipidemia and hypertension.
These conditions are related and share underlying mediators, mechanisms and pathways. It has become increasingly clear that certain CVD risks tend to cluster, or occur together. Furthermore, the lifestyle modifications of dietary change and increased physical activity can significantly affect several risk factors simultaneously and, in so doing, reduce the risk of CVD. In addition to its antioxidant and anti-inflammatory activity that weall know, the lipid-lowering and anti-glycaemic effects make curcumin a promising therapeutic for preventing and treating metabolic disorders and their related vascular complications.
Curcumin administration has also demonstrated positive effects on body weight and waist circumference, which are risk factors for metabolic diseases.
Curcuminasol185 is a nutraceutical food supplement based on curcumin extract (Curcuma Longa) highly bioavailable which exert anti-inflammatory effects. Both its absorption and power are 185 times better than native curcumin.
Curcuminasol185 has new standards:
• Its extraordinary power thanks to its high bioavailability, proven by clinical studies.
• Micellar curcurmin that facilitates curcumin absorption by bio-mimetism.
• Liquid formula.
• Vegetarian product.